• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Jumps Over 100 Points; US Jobless Claims Fall To 187,000

    1/18/24 9:47:20 AM ET
    $AGFY
    $ARAV
    $CELU
    $LYT
    Farming/Seeds/Milling
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGFY alert in real time by email

    U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining more than 100 points on Thursday.

    Following the market opening Thursday, the Dow traded down 0.33% to 37,143.30 while the NASDAQ rose 0.97% to 15,000.30. The S&P 500 also rose, gaining, 0.43% to 4,759.68.

    Check This Out: Alphabet, Electronic Arts And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

     

    Information technology shares rose by 1.4% on Thursday.

    In trading on Thursday, health care shares dipped by 0.9%.

     

    Top Headline

     

    U.S. initial jobless claims fell by 16,000 to 187,000 in the week ending January 18, compared to market estimates of 207,000.

     

    Equities Trading UP

     

    Agrify Corporation (NASDAQ:AGFY) shares shot up 133% to $2.75. Agrify said it entered into first Hydrocarbon Extraction Lab & Vertical Farming unit facility in California.

    Shares of Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) got a boost, surging 114% to $0.2032 after falling 5% on Wednesday.

    Celularity Inc. (NASDAQ:CELU) shares were also up, gaining 59% to $0.3013 after falling more than 5% on Wednesday.

     

    Equities Trading DOWN

     

    Aravive, Inc. (NASDAQ:ARAV) shares dropped 51% to $0.0541. Aravive intends to voluntarily terminate the listing of its common stock on the Nasdaq Global Select Market.

    Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) were down 29% to $0.1963. Processa Pharmaceuticals said it will effect a 1-for-20 reverse stock split.

    Newcourt Acquisition Corp (NASDAQ:NCAC) was down, falling 25% to $8.75 after gaining around 12% on Wednesday.

    Also Check This Out: How To Earn $500 A Month From Microsoft Stock Ahead Of Q2 Earnings Report

     

    Commodities

     

    In commodity news, oil traded up 0.7% to $73.05 while gold traded up 0.4% at $2,014.30.

    Silver traded down 0.4% to $22.585 on Thursday while copper fell 0.4% to $3.72.

     

    Euro zone

     

    European shares were higher today. The eurozone’s STOXX 600 rose 0.5%, London’s FTSE 100 rose 0.2% while Spain’s IBEX 35 Index rose 0.3% The German DAX gained 0.6% French CAC 40 rose 1% while Italy’s FTSE MIB Index climbed 1%.

    Construction output in the Eurozone fell by 2.2% year-over-year in November, while current account surplus rose to EUR 31.7 billion in November versus a revised EUR 6.6 billion in the year-ago period. Passenger car registrations in the European Union declined 3.3% year-over-year to 867.1 thousand units in December.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.03%, Hong Kong’s Hang Seng Index gaining 0.75% and China’s Shanghai Composite Index gaining 0.43%. India’s S&P BSE Sensex, meanwhile, fell 0.44%.

    Hong Kong’s seasonally adjusted unemployment rate came in unchanged at 2.9% in the three months ending December. Industrial production in Japan fell by 0.9% from a month ago in November, while Japan's core machinery orders declined 4.9% month-over-month in November.

     

    Economics

     

    U.S. initial jobless claims fell by 16,000 to 187,000 in the week ending January 18, compared to market estimates of 207,000.

    The Philadelphia Fed Manufacturing Index increased 2.2 points to a reading of -10.6 in January from -12.8 a month ago, versus market estimates of -7.

    Housing starts fell 4.3% month-over-month to an annualized rate of 1.46 million in December, while building permits increased by 1.9% to an annual rate of 1.495 million in December.


    Now Read This: Apple To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday

    Get the next $AGFY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGFY
    $ARAV
    $CELU
    $LYT

    CompanyDatePrice TargetRatingAnalyst
    Processa Pharmaceuticals Inc.
    $PCSA
    4/25/2024$8.00Buy
    H.C. Wainwright
    Aravive Inc.
    $ARAV
    4/17/2023$12.00Buy
    BTIG Research
    Celularity Inc.
    $CELU
    1/30/2023$5.00 → $1.00Equal-Weight → Underweight
    Morgan Stanley
    Celularity Inc.
    $CELU
    12/22/2022Outperform → Perform
    Oppenheimer
    Celularity Inc.
    $CELU
    6/22/2022$15.00Buy
    H.C. Wainwright
    Aravive Inc.
    $ARAV
    6/3/2022$15.00Buy
    ROTH Capital
    Celularity Inc.
    $CELU
    4/6/2022$10.00Buy → Hold
    Truist
    Agrify Corporation
    $AGFY
    3/23/2022Buy → Hold
    Craig Hallum
    More analyst ratings

    $AGFY
    $ARAV
    $CELU
    $LYT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres. Research & Development Young David converted options into 49 shares, increasing direct ownership by 0.56% to 8,752 units (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    2/4/26 5:09:36 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Business - Strategy Off Lin Patrick converted options into 193 shares, increasing direct ownership by 12% to 1,753 units (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    2/4/26 5:07:34 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Administrative Officer Guy Wendy converted options into 193 shares, increasing direct ownership by 18% to 1,256 units (SEC Form 4)

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    2/4/26 5:05:30 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ARAV
    $CELU
    $LYT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    H.C. Wainwright initiated coverage on AirGate PCS with a new price target

    H.C. Wainwright initiated coverage of AirGate PCS with a rating of Buy and set a new price target of $8.00

    4/25/24 6:22:04 AM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BTIG Research resumed coverage on Aravive with a new price target

    BTIG Research resumed coverage of Aravive with a rating of Buy and set a new price target of $12.00

    4/17/23 9:01:46 AM ET
    $ARAV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Celularity downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Celularity from Equal-Weight to Underweight and set a new price target of $1.00 from $5.00 previously

    1/30/23 7:11:17 AM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ARAV
    $CELU
    $LYT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses

    FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced receipt of $12.2 Million in net cash proceeds from the sale of approximately $126.3 Million of its unused New Jersey net operating losses (NOLs) and $1.9 Million of unused New Jersey research and development (R&D) tax credits. The NOLs and R&D tax credits sale was administered through New Jersey's Technology Business Tax Certificate Transfer Program, which enables qualified New Jersey-based technology and life science companies to sell their New Jersey NOLs and R&D tax credits for cash to buyers who purchase and

    2/10/26 8:30:00 AM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

    VERO BEACH, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that George Ng, Chief Executive Officer, and Patrick Lin, Chief Business & Strategy Officer and Founder, will attend the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, California. During the conference, Mr. Ng and Mr. Lin will be available for one-on-one meetings with investors and potential partners to discuss Processa's clinical pipeline, including the ongoing Phase 2 study evaluating NGC-Cap in patients with advanced or metastatic

    1/12/26 9:15:00 AM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

    Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies, today reported that it completed the enrollment and dosing of the 20 patients required for the planned formal interim analysis in its ongoing Phase 2 clinical study evaluating NGC-Cap, Processa's proprietary combination treatment of PCS6422 and capecitabine, in patients with advanced or metastatic breast cancer. "This is an important milestone because it allows us to assess whether NGC-Cap can demonstrate a meaningful improvement over capecitabin

    1/5/26 9:15:00 AM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ARAV
    $CELU
    $LYT
    SEC Filings

    View All

    Celularity Inc. filed SEC Form 8-K: Leadership Update

    8-K - Celularity Inc (0001752828) (Filer)

    1/21/26 4:30:34 PM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Celularity Inc.

    424B3 - Celularity Inc (0001752828) (Filer)

    1/8/26 6:15:19 AM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Celularity Inc.

    EFFECT - Celularity Inc (0001752828) (Filer)

    1/8/26 12:15:27 AM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ARAV
    $CELU
    $LYT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim CEO Kovler Benjamin bought $36,700 worth of shares (1,000 units at $36.70), increasing direct ownership by 6% to 17,000 units (SEC Form 4)

    4 - RYTHM, Inc. (0001800637) (Issuer)

    9/3/25 4:35:48 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Interim CEO Kovler Benjamin bought $46,700 worth of shares (1,000 units at $46.70), increasing direct ownership by 7% to 16,000 units (SEC Form 4)

    4 - RYTHM, Inc. (0001800637) (Issuer)

    9/2/25 4:36:32 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Large owner Rslgh, Llc bought $813,869 worth of shares (32,300 units at $25.20) (SEC Form 4)

    4 - Agrify Corp (0001800637) (Issuer)

    5/29/25 6:14:09 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    $AGFY
    $ARAV
    $CELU
    $LYT
    Leadership Updates

    Live Leadership Updates

    View All

    Agrify Announces Appointment of Peter Shapiro and Sanjay Tolia to Board of Directors

    TROY, Mich., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) ("Agrify" or the "Company"), a leading provider of branded innovative solutions for the cannabis and hemp industries, today announced that Peter Shapiro and Sanjay Tolia have been appointed to its Board of Directors, effective January 31, 2025. The Company also announced Richard Drexler's departure from the Board, also effective January 31, 2025.  "We are excited to welcome Peter and Sanjay to our Board of Directors at this critical time for our industry," said Agrify Chairman and Interim CEO Ben Kovler. "Their expertise and vision align with our commitment to shaping the future of THC consumption in Amer

    2/5/25 7:00:00 AM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Agrify Corporation Announces Plans to Acquire the Señorita Brand of THC Beverages

    Move would position Agrify to be a leader in the fast-growing, hemp-derived legal THC Beverage market Formulated by renowned winemakers Charles Bieler and Joel Gott, popular rapid growth beverage brand is currently distributed in nine states and Canada TROY, Mich., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), a leading provider of solutions for the cannabis industry, today announced that it has signed a non-binding letter of intent to acquire certain assets from Double or Nothing LLC, the owner and creator of the Señorita brand of hemp-derived legal THC ("HDLT") drinks, in exchange for 530,000 shares of Agrify common stock or common sto

    11/12/24 7:00:00 AM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Celularity Appoints Richard J. Berman to its Board of Directors

    FLORHAM PARK, N.J., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) (the "Company"), a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced today the appointment of Richard J. Berman, to its Board of Directors. Mr. Berman is an experienced public company director whose career spans over 40 years of venture capital, senior management, and merger and acquisitions experience. He has served as a director and/or officer of over a dozen public and private companies in the last five years, six of which have reached over one billion dollars in market value. Previously, Mr. Berman worked at Gol

    8/28/24 4:45:00 PM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ARAV
    $CELU
    $LYT
    Financials

    Live finance-specific insights

    View All

    Agrify Corporation to Change Its Name to RYTHM, Inc. Following Brand Portfolio Acquisition

    Acquires brand portfolio including RYTHM, Dogwalkers, and Beboe from Green Thumb IndustriesEnters into licensing agreement permitting Green Thumb to manufacture and distribute brandsUnder the new name, RYTHM, Inc. will assume the Nasdaq ticker symbol "RYM" starting September 2, 2025 ROLLING MEADOWS, Ill., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Agrify Corporation (NASDAQ:AGFY) ("Agrify" or the "Company"), a leading provider of branded innovative solutions for the cannabis and hemp industries, today announced the acquisition of a portfolio of brand intellectual properties (the "Brands"), including RYTHM, Dogwalkers, Beboe and others, from Green Thumb Industries for US$50 million paid for via a c

    8/27/25 4:20:00 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

    First patient dosed in Phase 2 clinical trial with NGC-Cap for metastatic breast cancer Positive data from preclinical studies support NGC-Iri's ability to deliver more SN-38 to tumors compared with either irinotecan or Onivyde® HANOVER, Md., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, provides updates on its product pipeline, upcoming milestones and business activities, and reports financial results for the three and nine months ended September 30, 2024. "We continued to make progres

    10/30/24 4:15:00 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Celularity Provides Corporate Update

    FLORHAM PARK, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative and cellular medicine company, has issued a Corporate Update to Shareholders from Robert J. Hariri, M.D., Ph.D., Founder, Chairman, and CEO. Dear Shareholders, I am pleased to share recent developments at Celularity, including an update on our commercial-stage advanced biomaterial products business. Let me start by reiterating what we said in our announcement last week, which is that we are resolutely committed to regaining full compliance with Nasdaq's listing requirements. We acknowledge the importance of timely filings and have been diligently working with our new auditi

    10/22/24 8:30:00 AM ET
    $CELU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGFY
    $ARAV
    $CELU
    $LYT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Agrify Corporation

    SC 13D/A - Agrify Corp (0001800637) (Subject)

    11/29/24 4:30:03 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form SC 13D filed by Agrify Corporation

    SC 13D - Agrify Corp (0001800637) (Subject)

    11/13/24 5:06:38 PM ET
    $AGFY
    Farming/Seeds/Milling
    Consumer Staples